FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1406 October 31, 1996 Number 18 Next

Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Grodstein, F.

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease . On page 453, the first two sentences of the Results paragraph of the Abstract should have read, "We observed a marked decrease in the risk of major coronary heart disease among women who took estrogen with progestin (multivariate adjusted relative risk, 0.39; 95 percent confidence interval, 0.19 to 0.78) or estrogen alone (relative risk, 0.60; 95 percent confidence interval, 0.43 to 0.83), as compared with women who did not use hormones."

This article has been cited by other articles:

• Grodstein, F., Manson, J. E. (2003). Relationship Between Hormone Replacement Therapy, Socioeconomic Status, and Coronary Heart Disease. JAMA 289: 44-44 [Full Text]  
• Waters, D. D., Alderman, E. L., Hsia, J., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P., Tardif, J. C., Higginson, L., Bittner, V., Steffes, M., Gordon, D. J., Proschan, M., Younes, N., Verter, J. I. (2002). Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial. JAMA 288: 2432-2440 [Abstract] [Full Text]  
• Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., Allan, J. D. (2002). Postmenopausal Hormone Replacement Therapy: Scientific Review. JAMA 288: 872-881 [Abstract] [Full Text]